glutamine has been researched along with Liver Cirrhosis in 100 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (37.00) | 18.7374 |
1990's | 16 (16.00) | 18.2507 |
2000's | 14 (14.00) | 29.6817 |
2010's | 21 (21.00) | 24.3611 |
2020's | 12 (12.00) | 2.80 |
Authors | Studies |
---|---|
Feng, J; Fu, Q; Guo, J; Ling, B; Ning, K; Wang, J; Wu, B; Xiu, G; Xu, J | 1 |
Gu, L; Li, X; Liu, Y; Peng, J; Wu, J; Xu, B; Yin, X; Zhang, F; Zhuge, Y | 1 |
Abdelshaheed, C; Brew, BJ; Chaganti, J; Cysique, L; Danta, M; Lockart, I; Montagnese, S; Tun, N; Zeng, G | 1 |
Alvarado, E; Canalda-Baltrons, A; Clària, J; Cuyàs, B; Escorsell, À; Guarner, C; Laghi, L; Lan, Q; Manichanh, C; Nieto, JC; Poca, M; Román, E; Sánchez, E; Sánchez-Rodríguez, MB; Soriano, G; Vidal, S | 1 |
Chen, N; Ke, C; Liu, Y; Shi, K; Tu, J; Wang, B; Wang, Y; Zhou, Z | 1 |
Ampuero, J; Camacho, I; Gil, A; Millán, R; Rico, MC; Romero-Gómez, M; Viloria, MDM | 1 |
Abdelmalek, MF; Bashir, MR; Chitneni, SK; Diehl, AM; Du, K; Henao, R; Hyun, J; Moylan, CA; Naggie, S; Premont, RT; Suzuki, A; Wang, Y | 1 |
Jaffe, A; Jakab, SS; Lim, JK | 1 |
Cheng, ML; Lai, MW; Liang, KH; Lin, WR; Lin, YH; Lo, CJ; Yeh, CT | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Bakker, BM; Bechmann, LP; Faber, KN; Heegsma, J; Moshage, H; Serna-Salas, SA; Smith-Cortinez, N; Sydor, S; van Eunen, K | 1 |
Chen, X; Ding, Y; Gao, M; He, N; Lin, H; Shen, W; Xu, X; Zhu, B | 1 |
Jalan, R; Thabut, D; Weiss, N | 1 |
Bu, S; Chang, N; Fan, J; Ghazwani, M; He, F; Huang, Y; Li, J; Li, L; Li, S; Liu, K; Ma, X; Xie, W | 1 |
Choi, SS; Dalton, GD; Diehl, AM; Du, K; Hyun, J; Jung, Y; Michelotti, GA; Premont, RT; Rizi, BS; Swiderska-Syn, M; Thelen, E | 1 |
Chan, SY; Harvey, LD | 1 |
Holeček, M; Vodeničarovová, M | 1 |
Kircheis, G; Lüth, S | 1 |
Ahluwalia, V; Bajaj, JS; Bouneva, I; Fuchs, M; Gilles, H; Heuman, DM; Kraft, KA; Luketic, V; Puri, P; Sanyal, AJ; Sterling, RK; Stravitz, RT; Thacker, L; Wade, JB | 1 |
Holecek, M | 2 |
Cojocariu, C; Irimia, R; Sfarti, C; Stanciu, C; Trifan, A | 1 |
Chen, YC; Li, YH; Meng, LP; Ye, JL; Zhu, JS | 1 |
Castro-Chávez, A; Florian-Soto, C; Heras-Romero, Y; Montes, S; Ríos, C; Rivera-Mancía, S | 1 |
Chand, L; Han, MK; Jeong, YJ; Kim, CY; Lee, SO; Shrestha, N | 1 |
Aldámiz-Echevarría, L; De Las Heras, J; Delgado, TC; Martínez-Chantar, ML | 1 |
Arroyo, V; Baccaro, ME; Ginès, P; Gómez-Ansón, B; Guevara, M; Martín-Llahí, M; Monté-Rubio, GC; Rami, L; Ríos, J; Torre, A; Torres, F | 1 |
Ahl, B; Berding, G; Bokemeyer, M; Buchert, R; Goldbecker, A; Lichtinghagen, R; Weissenborn, K; Wilke, F | 1 |
Dickinson, K; Gargosky, S; Lowe, ME; Martinez, A; McGuire, BM; Mokhtarani, M; Monteleone, J; Scharschmidt, BF; Syplyviy, VA; Xiao, X; Zupanets, IA | 1 |
Blamire, AM; Mardini, H; Record, CO; Smith, FE | 1 |
Hirayama, A; Honma, M; Igarashi, K; Ikeda, S; Kashikura, K; Kawata, S; Mori, M; Nihei, K; Otsuka, M; Saito, T; Sakuragawa, T; Soga, T; Suematsu, M; Sugimoto, M; Suzuki, H; Tomita, M; Tsuji, S; Watanabe, H; Yamamoto, T; Yatomi, Y; Yoshida, H | 1 |
Burkhard, PR; Ditisheim, S; Giostra, E; Goossens, N; Hadengue, A; Mentha, G; Spahr, L | 1 |
Blanco Vela, CI; Poo Ramírez, JL | 1 |
Ahluwalia, V; Bajaj, JS; Bouneva, I; Fuchs, M; Gilles, H; Heuman, DM; Kraft, KA; Luketic, V; Monteith, P; Noble, NA; Puri, P; Sanyal, AJ; Sterling, RK; Stravitz, RT; Wade, JB; White, MB | 1 |
Abcouwer, SF; Bode, BP; Conroy, JL; Fuchs, BC; Hurley, BP; Rhoads, DB; Souba, WW; Suetterlin, JE; Tanabe, KK | 1 |
Amodio, P; Del Piccolo, F; Efrati, C; Masini, A; Merli, M; Nicolao, F; Riggio, O | 1 |
Davies, N; Jalan, R; Shawcross, D | 1 |
DAVIDSON, CS; SCHWARTZ, R; SEEGMILLER, JE | 1 |
GORDON, BG | 1 |
WEWALKA, F | 1 |
BODONYI, E; GILON, E; SZEINBERG, A; TAUMAN, G | 1 |
BERTHAUX, N; SCHWARZMANN, V | 1 |
CHIOFFALO, N; CUEVAS, M; CUEVAS, N; GALVEZ, S; KATZ, R; KLINGER, J; VACCAREZZA, A; VELASCO, M | 1 |
BEL, A; DORCHE, J; GIRARD, M; MINAIRE, Y; REVILLARD, JP; VALLON, C | 1 |
DORCHE, J; GIRARD, M; MINAIRE, Y; REVILLARD, JP | 1 |
DASTUR, DK; SESHADRI, R; TALAGERI, VR | 1 |
TOBE, BA | 1 |
BRULICH, M; KISFALUDY, S | 1 |
KENNAN, AL | 1 |
KOCHAR, BK; LAHA, PN | 1 |
RAULDUMM, F; SCHAPOSNIK, F | 1 |
KNAUFF, HG; MILLER, B; SEYBOLD, D | 1 |
WHITEHEAD, TP; WHITTAKER, SR | 1 |
Alonso, J; Córdoba, J; Esteban, R; Guardia, J; Jacas, C; Ortiz, M; Quiroga, S; Rovira, A | 1 |
Balata, S; Deutz, NE; Hayes, PC; Jalan, R; Marshall, I; Olde Damink, SW; Shawcross, DL; Wardlaw, J; Williams, R | 1 |
Graziadei, IW; Hinterhuber, H; Kugener, A; Marksteiner, J; Mattedi, M; Mechtcheriakov, S; Schocke, M; Vogel, W | 1 |
Gregor, M; Hass, HG; Hösl, F; Kaiser, S; Nägele, T; Seeger, U | 1 |
El-Kady, AM; El-Kial, AA; Hammady, SH; Khedr, MM; Risk, M | 1 |
Angelico, M; Bergamini, A; Bolacchi, F; Cadioli, M; Cozzolino, V; Orlacchio, A; Simonetti, G | 1 |
Fujiwara, M; Higashi, T; Nagashima, H; Nakatsukasa, H; Sakata, T; Shiota, T; Takei, N; Watanabe, A | 1 |
Bradley, JF; Burns, J; Fallon, A; O'D McGee, J | 1 |
Goić, A; González, M; Velasco, C; Velasco, M | 1 |
McCullough, AJ; Mullen, KD; Teran, JC | 1 |
Kato, Y; Kouno, M; Miyashita, M; Mizuno, H; Okabe, K; Sato, A; Suzuki, H; Suzuki, M; Tominaga, T | 1 |
Bayer, S; Ernst, T; Gerok, W; Häussinger, D; Hennig, J; Langer, M; Laubenberger, J; vom Dahl, S | 1 |
Ernst, T; Jacobson, S; Korula, J; Kreis, R; Moats, RA; Ross, BD; Shonk, T; Villamil, F | 1 |
Druml, W; Hübl, W; Lochs, H; Roth, E | 1 |
Goldberg, M; Hirschberger, J; Sauer, UG | 1 |
Blüml, S; Danielsen, ER; Ross, BD | 1 |
Bayer, S; Gufler, H; Häussinger, D; Hennig, J; Langer, M; Laubenberger, J | 1 |
Al-Mardini, H; Oppong, KN; Record, CO; Thick, M | 1 |
Plauth, M; Roske, AE | 1 |
Kim, ST; Lee, JH; Lee, YS; Lim, TH; Min, YI; Mun, CW; Seo, DW; Suh, DJ | 1 |
Bell, JD; Buckley, C; Changani, KK; Hodgson, HJ; Taylor-Robinson, SD | 1 |
Amodio, P; Attili, AF; Ceccanti, M; Efrati, C; Masini, A; Merli, M; Riggio, O | 1 |
Lochs, H; Plauth, M; Romaniuk, P; Roske, AE; Roth, E; Ziebig, R | 1 |
Blei, AT | 1 |
Efrati, C; Masini, A; Merli, M; Riggio, O; Valeriano, V | 1 |
Cho, SG; Choi, W; Hong, KC; Kim, HJ; Kim, MY; Kim, YB; Kim, YS; Lee, JH; Shin, SH; Suh, CH | 1 |
Higashi, T; Nakamura, SI; Nakatsukasa, H; Nouso, K; Tsuji, T; Watanabe, A; Yoshida, Y | 1 |
Fischer, JE; James, JH; Jeppsson, B; Ziparo, V | 1 |
Naganuma, T; Okabe, S; Takagi, K; Takeuchi, K; Urushidani, T | 1 |
Hoyer, S; Kommerell, B; Lanzinger, G; Papenberg, J | 1 |
Cabanel, M; Lantuit, P; Paccalin, J; Traissac, FJ | 1 |
Ganda, OP; Ruderman, NB | 1 |
Goto, I; Matsuno, T | 1 |
Takao, T; Ukida, M | 1 |
Butterworth, RF; Giguère, JF; Lavoie, J; Layrargues, GP | 1 |
Van Leuven, F; Weyne, J | 1 |
Fischer, JE | 1 |
Bauer, M; Schirardin, H; Warter, J | 1 |
Sasamoto, T | 1 |
Kattermann, R; Schenzer, R; Schlaeger, R | 1 |
Alroy, G; Eisenkraft, B; Itskovitch, J; Valero, A | 1 |
Dhatt, PS; Gupta, HL; Singh, H | 1 |
Host, WR; Rush, BF; Serlin, O | 1 |
Hupli, V; Konttinen, A; Salmenkivi, K | 1 |
Galli, C; Maiolo, AT; Polli, EE; Porro, GB; Sessa, M | 1 |
Hamlin, EM; Hourani, BT; Reynolds, TB | 1 |
Alroy, G; Stein, A; Valero, A | 1 |
12 review(s) available for glutamine and Liver Cirrhosis
Article | Year |
---|---|
Pathophysiology of Hepatic Encephalopathy.
Topics: Ammonia; Animals; Astrocytes; Diabetes Complications; gamma-Aminobutyric Acid; Gastrointestinal Microbiome; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Histamine; Humans; Inflammation; Liver Cirrhosis; Manganese; Microglia; Oxidative Stress; Serotonin; Tumor Necrosis Factor-alpha | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy.
Topics: Ammonia; Animals; Brain; Dipeptides; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Liver; Liver Cirrhosis; Muscles; Rats; Signal Transduction | 2019 |
Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications.
Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Disease Models, Animal; Glutamine; Hepatic Encephalopathy; Humans; Ketoglutaric Acids; Kidney; Liver Cirrhosis; Muscle, Skeletal; Phenylbutyrates | 2013 |
Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.
Topics: Amino Acids, Aromatic; Amino Acids, Branched-Chain; Ammonia; Brain; Dietary Proteins; Glutamine; Hepatic Encephalopathy; Humans; Hyperammonemia; Inflammation; Liver Cirrhosis; Muscle, Skeletal | 2015 |
An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease.
Topics: Ammonia; Animals; Benzoates; Drug Design; Glutamine; Humans; Liver Cirrhosis; Liver Diseases; Liver Failure, Acute; Nitrogen; Phenylacetates; Phenylbutyrates; Urea Cycle Disorders, Inborn | 2017 |
The molecular pathogenesis of hepatic encephalopathy.
Topics: Ammonia; Animals; Astrocytes; Brain; Gene Expression Regulation; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Failure, Acute | 2003 |
Glutamine--a conditionally essential amino acid in cirrhosis?
Topics: Amino Acids, Essential; Glutamine; Humans; Intestinal Mucosa; Liver Cirrhosis; Protein-Energy Malnutrition | 1995 |
Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy?
Topics: Animals; Astrocytes; Brain; Choline; Cognition Disorders; Disease Models, Animal; Glutamine; Hepatic Encephalopathy; Humans; Hydrogen; Inositol; Liver Cirrhosis; Liver Transplantation; Magnetic Resonance Spectroscopy; Portasystemic Shunt, Transjugular Intrahepatic; Protons | 1996 |
[Significance of small intestine mucosa as a metabolic organ].
Topics: Amino Acids; Ammonia; Animals; Energy Metabolism; Glutamine; Humans; Intestinal Mucosa; Intestine, Small; Liver; Liver Cirrhosis; Rats; Systemic Inflammatory Response Syndrome | 1998 |
Brain edema and portal-systemic encephalopathy.
Topics: Brain; Brain Edema; Flumazenil; Glutamine; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Necrosis; Prognosis | 2000 |
Hepatic coma in cirrhosis, portal hypertension, and following portacaval shunt. Its etiologies and the current status of its treatment.
Topics: Acute Disease; Amino Acids; Ammonia; Brain; Chronic Disease; Colon; Dietary Proteins; Fatty Acids; Glutamine; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Neomycin; Neurotransmitter Agents; Portacaval Shunt, Surgical; Postoperative Complications; Sterilization; Urease | 1974 |
9 trial(s) available for glutamine and Liver Cirrhosis
Article | Year |
---|---|
A multistrain probiotic increases the serum glutamine/glutamate ratio in patients with cirrhosis: a metabolomic analysis.
Topics: Glutamic Acid; Glutamine; Humans; Liver Cirrhosis; Metabolomics; Probiotics | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis.
Topics: Adult; Cross-Over Studies; Female; Glutamine; Humans; Hydrolysis; Lipase; Liver Cirrhosis; Male; Monte Carlo Method; Phenylbutyrates; Urea Cycle Disorders, Inborn | 2010 |
Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.
Topics: Aged; Biomarkers; Carcinoma, Hepatocellular; Diagnosis, Differential; Dipeptides; Fatty Liver; Female; Glutamine; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male; Metabolomics; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Protein Array Analysis; Reproducibility of Results | 2011 |
Effect of blood ammonia elevation following oral glutamine load on the psychometric performance of cirrhotic patients.
Topics: Administration, Oral; Adult; Aged; Ammonia; Female; Glutamine; Humans; Liver Cirrhosis; Male; Middle Aged; Psychometrics | 2003 |
Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia.
Topics: Adult; Aged; Amino Acids; Ammonia; Basal Ganglia; Brain Chemistry; Choline; Creatinine; Female; Glutamine; Humans; Hyperammonemia; Inositol; Liver Cirrhosis; Liver Function Tests; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Signal Transduction; Temporal Lobe | 2004 |
Glutamine study in hepatic schistosomiasis and effect of conventional medical therapy.
Topics: Animals; Anthelmintics; Biopsy; Glutamine; Humans; Liver; Liver Cirrhosis; Liver Diseases, Parasitic; Schistosomiasis mansoni | 1997 |
Evaluation of the severity of chronic hepatitis C with 3-T1H-MR spectroscopy.
Topics: Adult; Aged; Choline; Fatty Liver; Female; Glutamic Acid; Glutamine; Hepatitis C, Chronic; Humans; Lipid Metabolism; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Reproducibility of Results; Severity of Illness Index | 2008 |
Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities.
Topics: Adult; Brain Chemistry; Choline; Double-Blind Method; Female; Glutamine; Hepatic Encephalopathy; Humans; Inositol; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests | 1994 |
80 other study(ies) available for glutamine and Liver Cirrhosis
Article | Year |
---|---|
ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis.
Topics: Ammonia; Animals; Carbon Tetrachloride; Carcinoma, Hepatocellular; Diethylnitrosamine; Exosomes; Fibrosis; Glutamate-Ammonia Ligase; Glutamine; Hepatic Stellate Cells; Homeostasis; Liver Cirrhosis; Liver Neoplasms; Mice; Stromal Cells; Transforming Growth Factor beta | 2022 |
Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis.
Topics: Glutamate Dehydrogenase; Glutamic Acid; Glutamine; Hepatic Stellate Cells; Humans; Liver Cirrhosis | 2022 |
Novel magnetic resonance KTRANS measurement of blood-brain barrier permeability correlated with covert HE.
Topics: Blood-Brain Barrier; Brain; Choline; Glutamine; Hepatic Encephalopathy; Humans; Inositol; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Permeability | 2023 |
Atractylenolide III Ameliorates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting the PI3K/AKT Pathway and Regulating Glutamine Metabolism.
Topics: Animals; Bile Ducts; Fibrosis; Glutamine; Liver; Liver Cirrhosis; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2023 |
Oral glutamine challenge is a marker of altered ammonia metabolism and predicts the risk of hepatic encephalopathy.
Topics: Administration, Oral; Ammonia; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis | 2020 |
Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression.
Topics: Adult; Amino Acid Transport System ASC; Animals; Biomarkers; Cell Line; Cicatrix; Disease Models, Animal; Disease Progression; Female; Glutaminase; Glutamine; Hepatic Stellate Cells; Humans; Liver; Liver Cirrhosis; Male; Metabolomics; Mice; Middle Aged; Minor Histocompatibility Antigens; Myofibroblasts; Non-alcoholic Fatty Liver Disease; Positron-Emission Tomography | 2020 |
Plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study.
Topics: Age Factors; Aged; Area Under Curve; Carcinoma, Hepatocellular; Chromatography, Liquid; Cross-Sectional Studies; Disease Progression; Female; Glutamine; Humans; Liver Cirrhosis; Male; Middle Aged; Nuclear Magnetic Resonance, Biomolecular; Phenylalanine; Prodromal Symptoms; Prospective Studies; Risk; ROC Curve | 2020 |
Simultaneous Induction of Glycolysis and Oxidative Phosphorylation during Activation of Hepatic Stellate Cells Reveals Novel Mitochondrial Targets to Treat Liver Fibrosis.
Topics: Animals; Glutamine; Glycolysis; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Mitochondria, Liver; Mitochondrial Dynamics; Organelle Biogenesis; Oxidative Phosphorylation; Phenotype; Rats | 2020 |
Comprehensive metabolomics profiling reveals common metabolic alterations underlying the four major non-communicable diseases in treated HIV infection.
Topics: Adolescent; Adult; Aged; Alanine; Aspartic Acid; Atherosclerosis; Cognitive Dysfunction; Female; Glutamic Acid; Glutamine; Glycerophospholipids; HIV Infections; Humans; Liver Cirrhosis; Male; Metabolome; Middle Aged; Plasmalogens; Renal Insufficiency | 2021 |
Understanding hepatic encephalopathy.
Topics: Brain; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Failure, Acute | 2018 |
Regulation of hepatic stellate cell proliferation and activation by glutamine metabolism.
Topics: Animals; Cell Line; Cell Proliferation; Glutamine; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Male; Mice; Rats; Signal Transduction | 2017 |
Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Topics: Adaptor Proteins, Signal Transducing; Animals; Case-Control Studies; Cell Cycle Proteins; Cell Proliferation; Cell Transdifferentiation; Cells, Cultured; Cellular Reprogramming; Energy Metabolism; Gene Expression Regulation; Glutaminase; Glutamine; Hedgehog Proteins; Hepatic Stellate Cells; Humans; Ketoglutaric Acids; Liver; Liver Cirrhosis; Liver Cirrhosis, Experimental; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Liver; Myofibroblasts; Phenotype; Phosphoproteins; Rats; RNA Interference; Signal Transduction; Smoothened Receptor; Time Factors; Transcription Factors; Transfection; YAP-Signaling Proteins | 2018 |
YAPping About Glutaminolysis in Hepatic Fibrosis.
Topics: Glutamine; Humans; Liver Cirrhosis | 2018 |
Effects of branched-chain amino acids on muscles under hyperammonemic conditions.
Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Carbon Radioisotopes; Citric Acid Cycle; Glutamine; Hyperammonemia; In Vitro Techniques; Ketoglutaric Acids; Liver Cirrhosis; Methylhistidines; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle Proteins; Organ Specificity; Osmolar Concentration; Oxidation-Reduction; Protein Biosynthesis; Proteolysis; Rats, Wistar | 2018 |
Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.
Topics: Brain; Cognition; Cognition Disorders; Diuretics; Female; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Hyponatremia; Inositol; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Quality of Life; Sickness Impact Profile | 2013 |
Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis.
Topics: Administration, Oral; Adult; Ammonia; Area Under Curve; Biomarkers; Case-Control Studies; Female; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prospective Studies; Psychometrics; ROC Curve; Time Factors | 2013 |
Viability assessment of magnetic resonance spectroscopy for the detection of minimal hepatic encephalopathy severity.
Topics: Adult; Aspartic Acid; Basal Ganglia; Brain; Cognition; Creatine; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Hepatic Encephalopathy; Hepatitis; Humans; Inositol; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests | 2015 |
Bumetanide increases manganese accumulation in the brain of rats with liver damage.
Topics: Ammonia; Animals; Brain; Bumetanide; Glutamine; Liver Cirrhosis; Male; Motor Activity; Rats; Rats, Wistar | 2016 |
Glutamine inhibits CCl4 induced liver fibrosis in mice and TGF-β1 mediated epithelial-mesenchymal transition in mouse hepatocytes.
Topics: Animals; Apoptosis; Blotting, Western; Carbon Tetrachloride; Cell Proliferation; Cells, Cultured; Epithelial-Mesenchymal Transition; Female; Flow Cytometry; Glutamine; Hepatocytes; Liver; Liver Cirrhosis; Mice; Transforming Growth Factor beta1 | 2016 |
Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.
Topics: Adult; Aged; Aspartic Acid; Bilirubin; Brain Chemistry; Creatine; Creatinine; Female; Follow-Up Studies; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Hyponatremia; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parietal Lobe; Prognosis; Prospective Studies; Risk Factors; Sodium; Time Factors | 2009 |
Blood-brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controls.
Topics: Aged; Ammonia; Blood-Brain Barrier; Brain; Capillary Permeability; Female; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Middle Aged; Positron-Emission Tomography | 2010 |
Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia.
Topics: Amino Acids; Astrocytes; Body Water; Brain; Brain Edema; Glutamine; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Middle Aged; Multivariate Analysis | 2011 |
A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis.
Topics: Administration, Oral; Adult; Aged; Ammonia; Biomarkers; Capillaries; Cohort Studies; Female; Follow-Up Studies; Glutamine; Hematologic Tests; Hepatic Encephalopathy; Humans; Incidence; Liver Cirrhosis; Male; Middle Aged; Point-of-Care Systems; Predictive Value of Tests; Prevalence; Psychometrics | 2011 |
Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.
Topics: Administration, Oral; Ammonia; Dipeptides; Glutamine; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Cirrhosis; Quality of Life; Severity of Illness Index; Treatment Outcome; Urea | 2011 |
Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis.
Topics: Adult; Arginine; Aspartic Acid; Biomarkers; Brain; Cognition Disorders; Cross-Sectional Studies; Female; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Inositol; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prospective Studies | 2013 |
Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells.
Topics: Amino Acid Transport System ASC; Biological Transport; Blotting, Northern; Carcinoma, Hepatocellular; Carrier Proteins; Cell Division; Cells, Cultured; Fibroblasts; Glutamate-Ammonia Ligase; Glutamine; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Minor Histocompatibility Antigens; Reference Values; Reverse Transcriptase Polymerase Chain Reaction | 2002 |
The plasma ammonia and glutamine content in patients with hepatic coma.
Topics: Ammonia; Blood; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Plasma | 1954 |
[Ammonia and glutamine in the blood in atrophic liver cirrhosis before and after portacaval anastomosis].
Topics: Ammonia; Blood; Glutamine; Liver Cirrhosis; Portacaval Shunt, Surgical; Portal System; Veins; Venae Cavae | 1956 |
[Interperitoneal glutamine therapy of hepatic coma in cirrhosis].
Topics: Coma; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis | 1957 |
Glutamine estimation in cerebrospinal fluid in cases of liver cirrhosis and hepatic coma.
Topics: Body Fluids; Cerebrosides; Glutamine; Hepatic Encephalopathy; Humans; Inorganic Chemicals; Liver Cirrhosis; Regression Analysis | 1959 |
[Hyperammoniemia induced by glutamine in cirrhotics. The renal origin of this hyperammoniemia].
Topics: Ammonia; Glutamine; Humans; Hyperammonemia; Kidney; Liver Cirrhosis | 1962 |
[Blood ammonium, glutamine in the cerebrospinal fluid, the electroencephalogram and the neurological examination in relation to states of consciousness in hepatic patients].
Topics: Ammonia; Ammonium Compounds; Consciousness; Electroencephalography; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Neurologic Examination; Neurologic Manifestations | 1961 |
[Glutaminorachia during liver cirrhosis. Semeiological value of its modifications in "hepatic encephalopathies"].
Topics: Ammonia; Cerebrospinal Fluid; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis | 1962 |
[Cerebrospinal fluid glutamine in the course of liver cirrhosis].
Topics: Cerebrospinal Fluid; Glutamine; Liver Cirrhosis | 1963 |
LIVER-BRAIN RELATIONSHIPS IN HEPATIC COMA WITH SPECIAL REFERENCE TO AMMONIA AND KETO ACID METABOLISM.
Topics: Amino Acids; Ammonia; Blood; Blood Glucose; Brain; Glutamates; Glutamine; Glutarates; Hepatic Encephalopathy; Humans; Keto Acids; Lactates; Liver Cirrhosis; Metabolism; Proteins; Pyruvates; Urine | 1963 |
THE METABOLISM OF THE VOLATILE AMINES: VII. THE CLINICAL SIGNIFICANCE OF TWO COMPONENTS OF THE BLOOD AMMONIA LEVEL.
Topics: Amines; Ammonia; Arginine; Asparagine; Blood Chemical Analysis; Glutamates; Glutamine; Hematologic Tests; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Potassium; Proteins | 1964 |
[DETERMINATION OF AMMONIA IN DEPROTEINIZED BLOOD].
Topics: Amino Acids; Ammonia; Asparagine; Biomedical Research; Blood Chemical Analysis; Blood Proteins; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Trichloroacetic Acid | 1964 |
GLUTAMINE SYNTHETASE ACTIVITY IN RAT LIVER AFTER PORTACAVAL SHUNT.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glutamate-Ammonia Ligase; Glutamine; Insulin; Ligases; Liver; Liver Cirrhosis; Metabolism; Portacaval Shunt, Surgical; Rats; Research | 1964 |
CEREBROSPINAL FLUID GLUTAMINE LEVEL IN PORTAL CIRRHOSIS OF THE LIVER.
Topics: Alkaline Phosphatase; Blood Proteins; Cerebrospinal Fluid; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Function Tests | 1964 |
[CLINICAL SIGNIFICANCE OF THE DETERMINATION OF GLUTAMINE IN THE CEREBROSPINAL FLUID. (RESULTS IN 50 CASES)].
Topics: Cerebrospinal Fluid; Diagnosis, Differential; Glutamine; Hepatic Encephalopathy; Humans; Liver; Liver Cirrhosis; Liver Diseases; Metabolism; Pathology | 1964 |
[FREE PLASMA AMINO ACIDS IN LIVER CIRRHOSIS AND HEPATITIS].
Topics: Alanine; Amino Acids; Blood; Chromatography; Glutamine; Glycine; Hepatitis; Humans; Ion Exchange Resins; Liver Cirrhosis; Methionine; Phenylalanine; Proline; Serine; Taurine; Threonine; Tyrosine | 1964 |
A method for the determination of glutamine in cerebrospinal fluid and the results in hepatic coma.
Topics: Cerebrospinal Fluid; Coma; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis | 1955 |
Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts.
Topics: Administration, Oral; Adult; Ammonia; Area Under Curve; Brain; Cardiovascular Abnormalities; Female; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nervous System Diseases; Neuropsychological Tests; Portal System; Tomography, Spiral Computed | 2004 |
Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy.
Topics: Aspartic Acid; Cerebral Cortex; Choline; Creatinine; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Hepatic Encephalopathy; Humans; Inositol; Intelligence Tests; Liver Cirrhosis; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Memory; Memory, Short-Term; Mental Recall; Middle Aged; Neuropsychological Tests; Psychomotor Performance; Trail Making Test | 2005 |
[Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
Topics: Adult; Ammonia; Brain; Choline; Combined Modality Therapy; Creatinine; Diet, Protein-Restricted; Dipeptides; Energy Metabolism; Female; Follow-Up Studies; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Infusions, Intravenous; Inositol; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Pilot Projects; Prospective Studies; Reference Values; Statistics as Topic | 2005 |
Glutamic acid and glutamine levels in serum and cerebrospinal fluid in hepatic encephalopathy.
Topics: Adult; Aged; Ammonia; Female; Glutamates; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Hepatitis; Humans; Liver Cirrhosis; Male; Middle Aged; Tyrosine | 1984 |
Collagen stimulating factors in hepatic fibrogenesis.
Topics: Animals; Ascorbic Acid; Cell Line; Chromatography, Gel; Collagen; DNA; Fibroblasts; Glutamine; Humans; Liver; Liver Cirrhosis; Male; Mice; Procollagen-Proline Dioxygenase; Protein Biosynthesis; Tissue Extracts | 1984 |
[Glutamine in cerebrospinal fluid in the diagnosis of altered consciousness of hepatic origin].
Topics: Adolescent; Adult; Aged; Cognition Disorders; Consciousness Disorders; Female; Glutamine; Hepatic Encephalopathy; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged | 1984 |
Clinical significance of measuring plasma concentrations of glutamine and glutamate in alcoholic liver diseases.
Topics: Acute Disease; Biomarkers; Carcinoma, Hepatocellular; Chronic Disease; Fatty Liver, Alcoholic; gamma-Glutamyltransferase; Glutamates; Glutamic Acid; Glutamine; Hepatitis; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Liver Diseases, Alcoholic; Liver Neoplasms; Temperance | 1993 |
Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Brain Chemistry; Brain Diseases; Female; Glutamine; Hepatic Encephalopathy; Humans; Inositol; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Osmolar Concentration; Protons; Water-Electrolyte Imbalance | 1994 |
Importance of liver and kidney for the utilization of glutamine-containing dipeptides in man.
Topics: Adult; Amino Acids; Dipeptides; Female; Glutamine; Humans; Kidney; Kidney Failure, Chronic; Liver; Liver Cirrhosis; Male; Middle Aged; Reference Values | 1994 |
Glutamine and glutamate in ascitic fluid of dogs.
Topics: Amino Acids; Animals; Ascites; Ascitic Fluid; Dog Diseases; Dogs; Glutamates; Glutamic Acid; Glutamine; Heart Failure; Hypoproteinemia; Liver Cirrhosis; Neoplasms; Peritonitis | 1993 |
Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis.
Topics: Aged; Brain; Female; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Reference Values | 1997 |
Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study.
Topics: Adult; Ammonia; Electroencephalography; Female; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Psychomotor Performance | 1997 |
Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
Topics: Adult; Aged; Aspartic Acid; Basal Ganglia; Brain; Choline; Creatinine; Energy Metabolism; Female; Glutamine; Hepatic Encephalopathy; Humans; Inositol; Liver Cirrhosis; Liver Function Tests; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parietal Lobe; Prognosis; Prospective Studies | 1999 |
Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy.
Topics: Adult; Aged; Brain; Choline; Creatinine; Electroencephalography; Female; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Phosphates; Phosphorus Isotopes; Protons | 1999 |
Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation.
Topics: Administration, Oral; Ammonia; Analysis of Variance; Attention; Bacteria; Cathartics; Cognition; Colon; Disaccharides; Follow-Up Studies; Gastrointestinal Transit; Glutamine; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Jejunum; Liver Cirrhosis; Male; Memory; Middle Aged; Psychological Tests; Sugar Alcohols | 1999 |
Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration.
Topics: Adult; Ammonia; Enteral Nutrition; Glutamine; Humans; Intestine, Small; Liver Cirrhosis; Parenteral Nutrition; Portasystemic Shunt, Surgical; Postprandial Period | 2000 |
Effect of sodium benzoate on blood ammonia response to oral glutamine challenge in cirrhotic patients: a note of caution.
Topics: Administration, Oral; Ammonia; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Sodium Benzoate; Time Factors | 2000 |
Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings.
Topics: Adolescent; Adult; Biopsy; Female; Glucose; Glutamic Acid; Glutamine; Glycogen; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Lipids; Liver; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphates | 2001 |
Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis.
Topics: Ammonia; Glutamine; Humans; Liver Cirrhosis; Muscle, Skeletal; Zinc | 2001 |
Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Biological Transport; Blood-Brain Barrier; Brain; Dogs; Glucagon; Glutamine; Haplorhini; Hepatic Encephalopathy; Humans; Insulin; Liver Cirrhosis; Phenylalanine; Portacaval Shunt, Surgical; Rats; Tryptophan; Tyrosine | 1979 |
Effects of L-glutamine on acetylsalicylic acid-induced gastric lesions in normal and cirrhotic rats.
Topics: Animals; Aspirin; Carbon Tetrachloride Poisoning; Gastrointestinal Hemorrhage; Glutamine; Intestinal Secretions; Liver Cirrhosis; Male; Rats | 1975 |
Comparative studies of the electroencephalogram and the cerebral oxidative metabolism in patients with liver cirrhosis.
Topics: Ammonia; Brain; Brain Damage, Chronic; Cerebrovascular Circulation; Electroencephalography; Energy Metabolism; Glucose; Glutamates; Glutamine; Humans; Ketoglutaric Acids; Lactates; Liver Cirrhosis; Oxygen Consumption | 1975 |
[Our experience with the milk and cheese diet in the treatment of porto-caval encephalopathies and cirrhoses].
Topics: Alcoholism; Alkalosis; Ammonia; Animals; Brain Diseases; Cheese; Glutamine; Humans; Liver; Liver Cirrhosis; Milk; Muscle Contraction | 1975 |
Muscle nitrogen metabolism in chronic hepatic insufficiency.
Topics: Adult; Aged; Alanine; Alcoholism; Amino Acids; Ammonia; Brachial Artery; Female; Forearm; Glutamine; Hepatic Encephalopathy; Humans; Lactates; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Muscles; Nitrogen; Pyruvates; Veins | 1976 |
Glutaminase and glutamine synthetase activities in human cirrhotic liver and hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Glutamate-Ammonia Ligase; Glutaminase; Glutamine; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Mitochondria, Liver; Oxygen Consumption | 1992 |
[Amino acid metabolism in liver cirrhosis].
Topics: Administration, Oral; Amino Acids; Amino Acids, Branched-Chain; Ammonia; Glutamine; Humans; Hydrogen-Ion Concentration; Liver Cirrhosis | 1992 |
Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
Topics: Aged; Amino Acids; Aspartic Acid; Brain Chemistry; Chromatography, High Pressure Liquid; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged | 1987 |
Proceedings: Ammonia and amino acids in the brain of the rat with chronic hepatic failure.
Topics: Amino Acids; Ammonia; Animals; Aspartic Acid; Brain; Carbon Tetrachloride Poisoning; Chronic Disease; gamma-Aminobutyric Acid; Glutamates; Glutamine; Liver Cirrhosis; Male; Rats | 1974 |
[Action of ascorbic acid on ammoniemia, alpha-ketoglutaric acid, glutamic acid and glutamine in cirrhotic and normal subjects].
Topics: Ammonia; Ascorbic Acid; Glutamates; Glutamine; Humans; Ketoglutaric Acids; Liver Cirrhosis | 1967 |
[A biochemical study on hepatic fibrosis due to low protein diet (soba powder)].
Topics: Animals; Dietary Proteins; Glucose-6-Phosphatase; Glutamine; Hexosamines; Histocytochemistry; Hydroxyproline; Liver Cirrhosis; Mice; Protein Deficiency | 1967 |
[Serum gamma glutamyl transpeptidase in hepatobiliary diseases. Comparison with alkaline phosphatase and aryl amidase].
Topics: Acute Disease; Alanine Transaminase; Alkaline Phosphatase; Aminopeptidases; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chronic Disease; Glutamine; Hepatitis; Humans; Leucyl Aminopeptidase; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Pancreatitis | 1972 |
Ammonia metabolism in chronic obstructive pulmonary disease with special reference to congestive right ventricular failure.
Topics: Acid-Base Equilibrium; Adolescent; Adult; Aged; Ammonia; Carbon Dioxide; Cerebrovascular Disorders; Chronic Disease; Confusion; Electrocardiography; Glutamine; Heart Failure; Heart Ventricles; Humans; Hydrogen-Ion Concentration; Liver Circulation; Liver Cirrhosis; Lung Diseases, Obstructive; Middle Aged; Oxygen; Partial Pressure; Pulmonary Emphysema; Spinal Puncture; Spirometry; Sulfobromophthalein; Venous Pressure | 1974 |
Glutamine studies in Indian childhood cirrhosis.
Topics: Child; Glutamine; Humans; India; Liver Cirrhosis | 1974 |
Hyperalimentation in cirrhotic patients.
Topics: Acid-Base Equilibrium; Acidosis; Alanine Transaminase; Alkaline Phosphatase; Amino Acids; Ammonia; Arginine; Carbon Dioxide; Caseins; Catheterization; Cysteine; Diet Therapy; Fibrin; Glutamine; Glycine; Histidine; Humans; Isoleucine; Leucine; Liver; Liver Cirrhosis; Lysine; Methionine; Parenteral Nutrition; Phenylalanine; Potassium; Sodium; Threonine; Tryptophan | 1972 |
The diagnosis of hepatobiliary diseases by serum enzyme analyses.
Topics: Alkaline Phosphatase; Aminohydrolases; Aminopeptidases; Biliary Tract Diseases; Clinical Enzyme Tests; Glutamine; Guanine; Hepatitis; Humans; Liver Cirrhosis; Liver Neoplasms; Ornithine Carbamoyltransferase | 1971 |
Brain energy metabolism in hepatic coma.
Topics: Ammonia; Brain; Brain Diseases; Carbon Dioxide; Carbon Isotopes; Cerebrovascular Circulation; Glucose; Glutamine; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Liver Cirrhosis; Oxygen Consumption; Partial Pressure; Vascular Resistance | 1971 |
Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy.
Topics: Ammonia; Brain Diseases; Chemical and Drug Induced Liver Injury; Glutamine; Humans; Liver Cirrhosis; Methods | 1971 |
Cerebrospinal fluid glutamine, blood-CSF acid base balance and their relation to neurologic symptoms in chronic hypercapnia.
Topics: Acid-Base Equilibrium; Adolescent; Adult; Aged; Bronchitis; Cerebrovascular Disorders; Chronic Disease; Glutamine; Humans; Hydrogen-Ion Concentration; Hypercapnia; Liver Cirrhosis; Middle Aged; Neurologic Manifestations; Oxygen; Partial Pressure; Pulmonary Emphysema | 1971 |